PROFOUND MEDICAL CORP. Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount
PROFOUND MEDICAL CORP. (PROF) reported Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount of -$4.66 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes · last filed 2026-03-05
- PROFOUND MEDICAL CORP. effective income tax rate reconciliation, state and local income taxes, amount for fiscal 2025 was -$4.66M.
- PROFOUND MEDICAL CORP. effective income tax rate reconciliation, state and local income taxes, amount for fiscal 2024 was -$3.00M.
| Period end | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount 12 month |
|---|---|
| 2025-12-31 | -$4.66M 10-K · filed 2026-03-05 |
| 2024-12-31 | -$3.00M 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |